Name | 2,3,5-trimethyl-4-nitro-1-oxidopyridin-1-ium |
---|---|
Synonyms |
2,3,5-Trimethyl-4-nitropyridine 1-oxide
T6NJ AO B1 C1 DNW E1 N-oxide of 2,3,5-trimethyl-4-nitropyridine 2,3,5-Trimethyl-4-nitropyridine N-oxide Pyridine, 2,3,5-trimethyl-4-nitro-, 1-oxide 4-nitro-2,3,5-trimethyl pyridine-N-oxide 4-nitro-2,3,5-trimethylpyridine 1-oxide 2,3,5-trimethyl-4-nitropyridine-N-oxide Esomeprazole Impurity 21 |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 397.8±37.0 °C at 760 mmHg |
Molecular Formula | C8H10N2O3 |
Molecular Weight | 182.177 |
Flash Point | 194.4±26.5 °C |
Exact Mass | 182.069138 |
PSA | 71.28000 |
LogP | 0.83 |
Appearance | NA |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.565 |
HS Code | 2933399090 |
---|
~97% 86604-79-7 |
Literature: CONFORMA THERAPEUTICS CORPORATION Patent: WO2005/28434 A2, 2005 ; Location in patent: Page/Page column 332 ; |
~% 86604-79-7 |
Literature: US4555518 A1, ; |
~% 86604-79-7 |
Literature: Journal of Medicinal Chemistry, , vol. 35, # 6 p. 1049 - 1057 |
~% 86604-79-7 |
Literature: Journal of Medicinal Chemistry, , vol. 50, # 12 p. 2767 - 2778 |
Precursor 2 | |
---|---|
DownStream 10 | |
HS Code | 2933399090 |
---|---|
Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |